MedTrace Logo

International Pediatric Adrenocortical Tumor Registry

NCT00700414 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 9999

Last updated 2026-05-22

No results posted yet for this study

Summary

This study aims to collect demographic and medical information including detailed family history of cancer of children and adolescents with adrenocortical tumors in order to learn more about the clinical and epidemiological aspects, treatment modalities, and outcome of patients with this rare disease, worldwide.

In addition, investigators at St. Jude Children's Research Hospital (SJCRH) plan to perform molecular studies of tumor cells aimed to clarify the role of the TP53 gene and other genetic pathways in these tumors. They aim to obtain relevant biological material from participants with adrenocortical tumor (ACT), their biological parents, and relatives for determination of the TP53 germline status, molecular studies of the TP53 gene, and other molecular pathways.

Conditions

  • Adrenocortical Tumor

Sponsors & Collaborators

Principal Investigators

  • Raul C Ribeiro, MD · St. Jude Children's Research Hospital

Eligibility

Max Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2001-10-01
Primary Completion
2040-12-31
Completion
2040-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00700414 on ClinicalTrials.gov